PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 71 filers reported holding PASSAGE BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $68,136 | -36.2% | 10,730 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $106,871 | -24.8% | 10,730 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $142,065 | -24.3% | 10,730 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $187,560 | -31.6% | 10,730 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $274,366 | +207.2% | 10,730 | +57.5% | 0.00% | +200.0% |
Q3 2020 | $89,305 | -52.0% | 6,812 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $186,172 | – | 6,812 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $6,200,000 | 10.57% |
Lynx1 Capital Management LP | 2,752,422 | $3,441,000 | 3.10% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $1,545,000 | 2.89% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,122,000 | 1.85% |
Frazier Life Sciences Management, L.P. | 3,756,915 | $4,696,000 | 0.36% |
Orbimed Advisors | 8,931,999 | $11,165,000 | 0.21% |
Newtyn Management, LLC | 300,000 | $375,000 | 0.08% |
Deep Track Capital, LP | 1,439,062 | $1,799,000 | 0.08% |
Rubric Capital Management LP | 822,105 | $1,028,000 | 0.05% |
Oasis Management Co Ltd. | 240,000 | $300,000 | 0.05% |